Position in BNTX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$238,766
-$78,691 QoQ
Shares Held
2,566
-20.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#185
of 282 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BNTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Bridgefront Capital, LLC holds $16,100,567 across 34 Biotechnology names. BNTX ranks #25 (1.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
16,808 | $1,792,068 | |
| 2 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
11,282 | $1,252,640 | |
| 3 | AGIO |
Agios Pharmaceuticals, Inc.
|
31,097 | $1,154,009 | |
| 4 | TECH |
BIO-TECHNE Corp
|
15,017 | $1,060,951 | |
| 5 | SMMT |
Summit Therapeutics Inc.
|
60,416 | $880,261 | |
| 6 | BHVN |
Biohaven Ltd.
|
51,351 | $764,102 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
19,746 | $698,810 | |
| 8 | ELVN |
Enliven Therapeutics, Inc.
|
12,096 | $613,872 |
All Filings in BNTX
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $238,766 | 2,566 | Shares | Sole | 2026-08-14 | |
| 2025-09-30 | $317,457 | 3,219 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $263,406 | 2,474 | Shares | Sole | 2025-08-14 | |
| 2024-12-31 | $283,507 | 2,488 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||